169 results on '"A Turato"'
Search Results
2. The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis
3. Inhibition of CCAT/enhancer-binding protein beta-serpinB3 axis by 1-piperidin propionic acid: a new targeted therapy for non-alcoholic steatohepatitis
4. Development of new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma using patient-derived liver organoids
5. The CCAAT/Enhancer-Binding Protein beta - SerpinB3 axis inhibition as a novel strategy for Non-Alcoholic Steatohepatitis treatment
6. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response
7. Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma
8. The CCAAT/Enhancer-Binding Protein Beta - SerpinB3 Axis Inhibition as a Novel Strategy for Non-Alcoholic Steatohepatitis Treatment
9. The CCAAT/Enhancer-Binding Protein Beta - SerpinB3 Axis Inhibition as a Novel Strategy for Non-Alcoholic Steatohepatitis Treatment
10. Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma
11. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes a pro-tumorigenic inflammatory response
12. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
13. Engineering of galectin-3 for glycan-binding optical imaging
14. 'Speed up'! The Influences of the Hidden Curriculum on the Professional Identity Development of Medical Students
15. Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients
16. Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis
17. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma
18. LOMBALGIA E FEBRE EM HOMEM IDOSO: APENAS MAIS UMA PIELONEFRITE NO PRONTO‐SOCORRO?
19. FEBRE MACULOSA (FM) ‐ RELATO DE CASO
20. PERFIL EPIDEMIOLÓGICO DOS PACIENTES DIAGNOSTICADOS COM ABSCESSO HEPÁTICO PIOGÊNICO NO HOSPITAL DO SERVIDOR PÚBLICO DO ESTADO DE SÃO PAULO
21. Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression
22. SERPINB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis
23. In vivo antitumoral effect of 4-nerolidylcatechol (4-NC) in NRAS-mutant human melanoma
24. Profil psychosocial d’adolescents brésiliens vivant avec le VIH et adhérents au traitement : résultats de la cohorte Adoliance
25. FEBRE MACULOSA (FM) ‐ RELATO DE CASO
26. SerpinB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis
27. Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression
28. Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression
29. SerpinB3 inhibition as a novel target therapy for non-alcoholic steatohepatitis
30. Engineering of galectin-3 for glycan-binding optical imaging
31. FRI-117-The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity of portal hypertension and complications onset in patients with advanced liver disease
32. PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting
33. “Speed up”! The Influences of the Hidden Curriculum on the Professional Identity Development of Medical Students
34. FRI-117-The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity of portal hypertension and complications onset in patients with advanced liver disease
35. Meanings of the sickening process for patients with systemic lupus erythematosus: a review of the literature
36. The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity portal hypertension and complications onset in patients with advanced liver disease
37. Absence of NOD2 receptor predisposes to intestinal inflammation by a deregulation in the immune response in hosts that are unable to control gut dysbiosis
38. α1-Antitrypsin Polymerizes in Alveolar Macrophages of Smokers With and Without α1-Antitrypsin Deficiency
39. SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma
40. Pulmonary embolism severity index accurately predicts long‐term mortality rate in patients hospitalized for acute pulmonary embolism
41. Incidence and short-term prognosis of late sustained ventricular tachycardia after myocardial infarction: Results of the Gruppo Italiano per lo Studio della Sopravvivenza nell’Infarto Miocardico (GISSI-3) Data Base
42. The gain of function mutation of SerpinB3 (SCCA-PD) is associated with the severity portal hypertension and complications onset in patients with advanced liver disease
43. Physicians and alternative medicines in 'The Barber of Seville' by Gioachino Rossini: A bicentennial debate
44. Coronary Heart Disease and the Ischemic Demise of a Beloved Fictional Hero: Hercule Poirot of Agatha Christie Fame
45. pcDNA-IL-12 vaccination blocks eosinophilic inflammation but not airway hyperresponsiveness following murine Toxocara canis infection
46. New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma
47. PET-CT imaging of atherosclerosis in Ldlr-/- mice treated with an anti-LDL(-) nanoformulation
48. The immunomodulatory activity of the protease-inhibitor SerpinB3 in vivo and in vitro
49. Synoptic and hydrological analysis of a flood event
50. Role of SerpinB3 in the stimulation of macrophage activation marker sCD163 in HCV infected patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.